KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Equity Income (2016)

Charles River Laboratories International has reported Equity Income over the past 5 years, most recently at $442000.0 for Q3 2016.

  • Quarterly results put Equity Income at $442000.0 for Q3 2016, down 86.36% from a year ago — trailing twelve months through Sep 2016 was $8.7 million (up 58.08% YoY), and the annual figure for FY2015 was $3.8 million, down 58.89%.
  • Equity Income for Q3 2016 was $442000.0 at Charles River Laboratories International, down from $5.0 million in the prior quarter.
  • Over the last five years, Equity Income for CRL hit a ceiling of $6.1 million in Q1 2014 and a floor of -$907000.0 in Q2 2015.
  • Median Equity Income over the past 5 years was $1.1 million (2013), compared with a mean of $1.4 million.
  • Biggest five-year swings in Equity Income: skyrocketed 6882.22% in 2014 and later crashed 143.69% in 2015.
  • Charles River Laboratories International's Equity Income stood at -$373000.0 in 2012, then soared by 386.33% to $1.1 million in 2013, then soared by 80.06% to $1.9 million in 2014, then tumbled by 88.61% to $219000.0 in 2015, then soared by 101.83% to $442000.0 in 2016.
  • The last three reported values for Equity Income were $442000.0 (Q3 2016), $5.0 million (Q2 2016), and $3.1 million (Q1 2016) per Business Quant data.